Has $260,000 Position in NeoGenomics, Inc. (NASDAQ:NEO)

lessened its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 45.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,428 shares of the medical research company’s stock after selling 7,899 ’s holdings in NeoGenomics were worth $260,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Oppenheimer Asset Management Inc. boosted its holdings in shares of NeoGenomics…

Original Source